Author: OurCrowd

Sysmex, a $2.7 billion Japanese maker of blood testing machines, is in the cross-hairs of Sight Diagnostics, an Israeli company that announced December 4 that it had received FDA clearance for its competing product, OLO, according to Reuters. The US FDA 510(k) clearance will enable Sight to sell its OLO analyzer to laboratories run by diagnostic providers and hospitals. Read more...

Sight Diagnostics, an Israel-founded company that develops lab-grade blood testing systems, announced on Wednesday that it received Food and Drug Administration 510(k) clearance for its OLO analyzer, a device that performs blood tests and provides lab-grade results in minutes. Read more...